Institute of Tropical Medicine Antwerp
Foundation of Public Utility

Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk

DSpace/Manakin Repository

Files in this item

This item appears in the following Collection(s)